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Why validate diagnoses in 
electronic health records?
Over the last decades, the adoption of electronic 
health records (EHR) by health services worldwide 
has facilitated the construction of large population-
based patient databases. These routinely generated 
longitudinal records have an enormous potential 
for epidemiological and clinical research [1–3]. EHR 
contain information on the health of an individual 
and are an electronic version of a patient’s medical 
history. This contrasts with administrative claims 
data, whose main purpose is administration of 
reimbursement of medical services to healthcare 
providers. Due to the immense size of EHR, they 
can offer high statistical power and can often be 
representative of a population. Linkage between 
different EHR can further improve the completeness 
of the data. However, the primary raison d’être of 
most of these EHR is for clinical, administrative 
or audit purposes, which is a major challenge 
to their use for health research. Data elements 
that would be useful for research can therefore 
be wrongly classified, insufficiently specified or 
missing. Misclassified data can lead to systematic 
measurement errors. Missing data can lead to 
selection bias and counteract the statistical power 
provided by the magnitude of EHR [4].
Measuring data validity is therefore needed to 
establish whether the values “make sense” [5, 6]. 
When considering answering a research question 
using EHR, a researcher should always contemplate 
the following question: are we measuring what we 
are intending to measure?
The size of EHR does not resolve these data 
validity issues, and could even magnify these 
problems [7]. Big sample sizes can equally lead to 
big inferential errors if the validity of data is poor [8]. 
Whether the codes in an EHR database accurately 
capture the target condition (and thus minimise 
measurement errors) strongly affects the reliability 
of subsequent observational studies [9, 10]. The 
data validation process for research purposes is 
crucial to draw valid inference from these databases 
[4, 7, 11, 12]. In prospective cohort studies where 
one collects the data solely for the purpose of 
epidemiological research, application of stricter 
definitions for exposures, covariates and outcomes 
is possible, and specific tests or treatments that 
are not part of routine clinical practice can be 
requested, which is not the case when using EHR 
data. In addition, the validity of different diseases 
or conditions in EHR can vary within and between 
datasets. Some diseases (such as asthma) might 
be coded using combinations of diagnoses and/
or less specific symptoms, whereas the validity of 
diagnoses with very specific symptoms (such as 
tension pneumothorax) is likely to be higher.
Algorithm construction
EHR databases generally store diagnostic information 
using codes selected from a structured medical 
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dictionary. An algorithm consisting of a combination of 
codes can be constructed in order to identify all events 
of a target condition from the EHR database. These 
algorithms can consist of one or more diagnostic 
codes, or can include several other parameters, 
including medications, test results and disease 
symptoms. Additional inclusion or exclusion criteria 
can be included in the algorithm, such as age, sex or 
exclusion of other diseases [6]. These algorithms can 
be constructed manually or using machine-learning 
methods, to automate algorithm generation [13].
In general, if there are more parameters in an 
algorithm, it will identify fewer false positives. 
However, this comes with a trade-off, as the total 
identifiable population with the target condition 
will also decrease as fewer patients will fulfil all 
parameters, and the algorithm may only detect 
severe cases of the target condition. Furthermore, 
if two conditions have many overlapping parameters 
(for example, this is the case in asthma and chronic 
obstructive pulmonary disease (COPD)) [14], these 
parameters may not be very useful in differentiating 
between the two diseases and the inclusion of 
further parameters that can differentiate between 
the two conditions, or an exclusion based on the 
diagnostic code of the second disease, may be 
necessary. This process of code and parameter 
selection is therefore not always straightforward, 
hence the importance of considering their validity. 
The validity of an algorithm for a target condition 
within a database can be measured using separate 
test measures, which will be discussed in this article.
To avoid confusion, the word “validation” is 
frequently used in a variety of disciplines, including 
medicine and psychology, to measure the accuracy 
of an instrument or test. Examples of these are the 
degree to which evidence supports the interpretation 
of biomarkers or questionnaires for disease diagnosis. 
In most literature on healthcare databases, including 
this article, the term “validation” refers only to the 
reliability of coding.
Test measures
In research using EHR, the validity of codes and 
algorithms are quantified using diagnostic accuracy 
test measures, which relate what is recorded in the 
data to a recognised reference standard. The most 
commonly used and practical of these measures 
are the positive predictive value (PPV), the negative 
predictive value (NPV), the sensitivity and specificity. 
These test measures can be used to quantify the 
validity of an algorithm, and are a core concept of 
both epidemiology and instrument validation. The 
chosen test measure depends on the scope of the 
study. An overview of how these test measures are 
calculated is provided in table 1.
The PPV is the proportion of identified individuals 
with the target condition that truly have the target 
condition. The PPV is arguably the most practical 
test measure to validate an algorithm, as it can be 
measured using only a small sample of the population 
and reflects how accurate an algorithm is in identifying 
individuals with a target condition in EHR databases 
[15]. Similarly, the NPV is the proportion of individuals 
identified as negative that truly did not have the target 
condition. The NPV is useful, for example, to assess 
whether a control group that has been categorised 
as unexposed was truly unexposed.
Sensitivity measures the proportion of all individuals 
with a target condition that the algorithm identified 
correctly. An algorithm with a high sensitivity would 
detect a high proportion of all individuals with 
the target condition. The specificity measures the 
proportion of individuals that do not have the target 
condition that the algorithm correctly identified as 
negative. An algorithm with a high specificity would 
detect a high proportion of all individuals without 
the target condition. The sensitivity and specificity 
are important measures of the impact of missing 
data in the EHR data. If an algorithm fails to identify 
many individuals with a certain condition due to a low 
sensitivity, this can lead to selection bias. The specificity 
is important to consider when constructing control 
groups without the target condition. The prevalence of 
the target condition (or an estimate thereof) is required 
to calculate sensitivity or specificity values.
Sample validation techniques
There is no one-size-fits-all method of assessing 
the validity of algorithms in EHR. The optimal 
Table 1 Test measures
Reference standard Outcome Test measures
Positive Negative
Diagnostic algorithm
 Positive True positives correctly 
identified (A)
False positives (B) Total identified as 
positive
PPV=A/(A+B)
 Negative False negatives (C) True negatives correctly 
identified (D)
Total identified as 
negative
NPV=D/(C+D)
Outcome True positives True negatives
Test measures Sensitivity=A/(A+C) Specificity=D/(B+D)
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technique depends on the nature of the studied EHR 
database, the study question that needs answering 
and the way in which the diagnostic algorithm was 
constructed.
There are multiple ways to test the validity of 
these diagnostic algorithms in EHR. In a systematic 
review on validation studies in the General Practice 
Research Database, a large primary care UK EHR 
database that later evolved into the Clinical Practice 
Research Datalink (CPRD), Herrett et al. [16] 
divided the methods of the included studies into 
internal and external validation methods. External 
validation methods require dependable external 
reference standards (often referred to as “gold 
standard”), while internal validation methods do 
not require this external reference standard but 
will therefore not be able to quantify the discussed 
standard test measures.
The remainder of this section outlines a non-
exhaustive list of eight common techniques to 
validate diagnostic algorithms with references 
to examples, ranked loosely from most to least 
resource-intensive. There are other possible 
techniques, including studying the completeness, 
plausibility, uniformity and time patterns of the data, 
which are not described in detail with examples in 
this study [5]. Not all these validation techniques 
are necessarily implementable in each database 
and some techniques are resource-intensive, while 
others provide only an indication of the validity. The 
choice of techniques is dependent on the database 
and access to data. Table 2 provides an overview 
of the test measures that can be calculated or 
estimated with the discussed techniques.
Manual validation of physical 
records
This technique determines if the EHR reflect the 
physical chart of the patient by manually going 
through a sample of clinical notes. Historically, 
this method was used to test EHR reliability when 
EHR database systems were being implemented. If 
the physical records accurately reflect the patient’s 
status, this is a reliable way to test the validity of 
diagnostic codes. Weaknesses of this approach 
include the considerable time investment, and that 
these physical records may not always be available 
any more, as they tend to be phased out in favour 
of digital records. This technique also relies on the 
examination of physical records by someone who 
is usually not the treating physician, which can lead 
to misinterpretation. This technique is commonly 
used [17, 18].
Questionnaires for healthcare 
practitioners or patients
One can assess the “true” disease status of a patient 
by sending out questionnaires to either the patient 
or the healthcare professional responsible for their 
care. A questionnaire with appropriate design that 
can reliably ascertain the disease status of the 
individual patient is necessary for this technique. 
This technique can provide a reliable measure of 
the validity of an algorithm but can be resource-
intensive, and the option may not be available in all 
databases. In addition, the clinician may be using 
the EHR database to look up the patient diagnoses, 
and patients or clinicians may be less likely to answer 
in more complicated cases. The validity of asthma 
and COPD recording in the CPRD-Global Initiative 
for Chronic Obstructive Lung Disease (CPRD-GOLD) 
was assessed using this technique [19, 20].
Validation of machine-learning 
algorithms
If the diagnostic algorithms were created using 
machine-learning techniques, it is possible to 
Table 2 Test measures that it is possible to calculate or estimate by each validation technique
Technique PPV NPV Sensitivity Specificity
Manual validation of physical records Can be calculated Can be calculated Can be calculated Can be calculated
Questionnaires for healthcare practitioners 
or patients
Can be calculated Can be calculated
Validation of machine-learning algorithms Can be calculated Can be calculated Can be calculated Can be calculated
Comparison to an external database 
(complete overlap)
Can be calculated Can be calculated Can be calculated Can be calculated
Comparison of rates in a comparable 
population
Estimate only Estimate only
Internal validation using additional 
parameters
Estimate only Estimate only
Internal validation using free text in the 
database
Estimate only Estimate only
Sensitivity analyses using restrictive 
algorithms
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validate the algorithms within the database and 
create algorithms with high sensitivity values by 
varying the imbalance ratio between positive cases 
and negative cases. An example of this process was 
described by Afzal et al. [21]. Large amounts of 
data are usually required to derive, train and test 
the algorithm.
Comparison to an 
external database
If an independent secondary database is available, 
this can be a reliable and reasonably fast way to 
validate diagnostic algorithms. However, if the 
second database is not representative of the same 
population as the first database, results may not be 
generalisable. This technique was used by Edgren 
et al. [22] to compare data in a blood donation 
database to nationwide population and health 
registers in Denmark and Sweden.
Comparison of rates in a 
comparable population
A quick way to assess the credibility of recording of 
diagnostic coding is by comparing the prevalence or 
rates of the diagnostic code to the same measure in 
a comparable population. This technique is limited, 
as it can only provide rough estimates. In addition, if 
the over- and under-diagnosis rates of a disease are 
similar (i.e. there is systematic error affecting both), 
this technique will miss both measurement errors. 
This technique was used by Hansell et al. [23] to 
explore patterns in asthma and COPD morbidity 
and mortality.
Internal validation using 
additional parameters
This technique is most useful in algorithms 
consisting only of the diagnostic code. In essence, 
this method checks whether the patients who 
have received the diagnostic code also received 
treatment for that condition, have symptoms 
of the condition or were tested for the target 
condition. For example, the diagnosis of acute 
myocardial infarction was strengthened in a study 
by Andersohn et al. [24] by including only cases 
that also had codes for tests or treatments. This 
method requires a good degree of completeness in 
the data and certain data parameters not present 
in all data sources.
Internal validation using 
free text in the database
Similar to the previous technique, this technique 
checks whether the diagnosis is confirmed in 
available free text in the database. This is only 
available if the database offers free-text records, and 
the number of databases offering free-text access 
to researchers is declining due to confidentiality 
concerns. Yang et al. [25] confirmed colorectal 
cases by looking at free text in the database for 
confirmation of the cases.
Sensitivity analyses using 
restrictive algorithms
This method tests the soundness of study results 
using different diagnostic algorithms, so is an 
aggregate measure of both study analysis and 
diagnostic results. By comparing the baseline 
characteristics or measures of effects of a study 
using a broader algorithm (fewer parameters) and a 
narrower algorithm (more parameters), it is possible 
to assess whether results are driven by the inclusion 
or exclusion of patients in whom the diagnosis 
may be less certain. For example, the recording of 
vitamin D supplementation was assessed using 
sensitivity analyses in a study on cancer survival 
by Jeffreys et al. [26]. In this study, the analysis 
was restricted to women over the age of 60 years 
(as they received free vitamin D prescriptions at 
pharmacies and thus were less likely to obtain 
over-the-counter drugs); no difference in results 
was found.
Summary
When using large EHR databases for epidemiological 
or clinical research, it is paramount to be aware of 
the possibility of systematic measurement errors, 
as this can lead to large inferential errors. Validation 
studies help determine the degree of systematic 
measurement error and therefore aid in the 
interpretation of findings. Validation of diagnosis 
algorithms can help researchers by making their 
research in EHR more credible by quantifying the 
correctness of the data.
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